| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.6M | -19.3% |
| R&D Expense | $19.0M | +16.7% |
| SG&A Expense | $39.6M | +18.1% |
| Operating Income | -$70.2M | -16.9% |
| Pre-tax Income | -$189.1M | -85.9% |
| Income Tax | $198K | +14.5% |
| Net Income | -$189.3M | -85.8% |
| EPS (Basic) | -$1.42 | -69.0% |
| EPS (Diluted) | -$1.42 | -69.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $107.4M | +163.3% |
| Accounts Receivable | $2.3M | -28.9% |
| Current Assets | $157.4M | +82.9% |
| Total Assets | $247.0M | +52.7% |
| Current Liabilities | $12.4M | +2.0% |
| Long-term Debt | $273.6M | +400.9% |
| Total Liabilities | $333.3M | +198.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.7M | -33.5% |
| Capital Expenditures | $50K | -85.7% |
| Investing Cash Flow | -$64.6M | -63.6% |
| Financing Cash Flow | $120.5M | +243.2% |
| Free Cash Flow | -$50.8M | -32.4% |
| -$86.2M |
| -272.1% |